ATLASBeam Therapeutics (BEAM) earnings date: Nov 3, 2026
Beam Therapeutics (BEAM) reports earnings for the quarter ended Sep 30, 2026 on Tue, Nov 3, 2026, before the open. Analysts expect EPS of -$1.17.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on BEAM
| Last price | $27.23 (-5.6%) |
|---|---|
| Normal 1-day range (±1σ) | ±4.3% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 4 reports |
These figures come from the same calibrated model and valuation as the Beam Therapeutics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Beam Therapeutics reports on Nov 3, 2026. One email the day before, with ATLAS’s read on Beam Therapeutics. You can switch it off at any time.
Alert me before BEAM reportsFree to start. Creating an account takes under a minute.
BEAM earnings at a glance
| Next report (confirmed) | Tue, Nov 3, 2026 |
|---|---|
| Time | Before the open |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$1.17 |
| Last report | Aug 4, 2026 · Miss |
| Beat rate (last 4 reports) | 3 of 4 (75%) |
| Average EPS surprise | +96.6% |
| Average move around a report | ±2.7% (last 4) |
| Sector | Healthcare · Biotechnology |
Beam Therapeutics earnings history: last 4 reports
Beam Therapeutics last reported on Aug 4, 2026: EPS of -$1.18 against an estimate of -$1.13 (-4.4% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 4, 2026 | -$1.13 | -$1.18 | -4.4% | Miss | +4.5% |
| Jun 11, 2026 | -$0.33 | -$0.09 | +72.7% | Beat | -1.6% |
| May 7, 2026 | -$1.01 | -$0.91 | +9.9% | Beat | -0.1% |
| Feb 24, 2026 | -$1.12 | $2.33 | +308.0% | Beat | +4.5% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for BEAM
See the fair value, the probability range and the earnings history of Beam Therapeutics on its ATLAS page.
Beam Therapeutics (BEAM) stock analysisPlans from €3.99 a month.
Beam Therapeutics earnings: frequently asked questions
When does Beam Therapeutics (BEAM) report earnings?
Beam Therapeutics is scheduled to report on Tuesday, November 3, 2026, before the open. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for BEAM?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$1.17 per share (USD). Estimates can change before the report.
How often does BEAM beat earnings estimates?
Of its last 4 reports with a recorded result, Beam Therapeutics beat the EPS estimate 3 times; the average surprise was +96.6%. Past results do not predict the next one.
How much does BEAM move around earnings?
Over its last 4 reports the stock moved an average of 2.7% (absolute, from the close before the report day to the close after it), and finished higher 2 of 4 times.
Did Beam Therapeutics beat earnings estimates last quarter?
Beam Therapeutics last reported on Aug 4, 2026: EPS of -$1.18 against an estimate of -$1.13 (-4.4% surprise), a miss.
How much does BEAM usually move in a day?
On a normal trading day the ATLAS model puts BEAM’s one-day range at about ±4.3%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Tue, Nov 3, 2026
Educational information, not investment advice. Disclaimer